Skip to main content
Center for Professional Practice of Nursing

Center for Professional Practice of Nursing

References

  1. Domin, M.A. Highly virulent pathogens - a post antibiotic era? Br J Theatre Nurs 1998:8(2): 14-18.
  2. Garrett, L. The Coming Plague: Newly Emerging Diseases in a World Out of Balance, 1995, Penguin Books, p. 671.
  3. Levy, S.B. The challenge of antibiotic resistance. Sci Am March 1998.
  4. Bauchner, H., Pelton, S.I., and Klein, J.O. Parents, physicians and antibiotic use. Pediatrics 1999; 103(2):395-401.
  5. Nyquist, A.C., et al. Antibiotic prescribing for children with colds, URI's and bronchitis. JAMA 1998; 279(11):875-877.
  6. Gonzales, R., Steiner, J. F., Sande, M.A. Antibiotic prescribing for adults with colds, upper respiratory tract infections and bronchitis by ambulatory care physicians. JAMA 1997;278(11):901-904.
  7. Gaynes, R. P. Surveillance of nosocomial infections: A fundamental ingredient for quality. Infect Control Hosp Epidemiol 1997; 18(7): 475-478.
  8. Vincent, J.L., et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA 1995;274 (8):639-644.
  9. Weber, D.J., Raasch, R., and Rutala, W.A. Nosocomial infections in the ICU: The growing importance of antibiotic-resistant pathogens. Chest 1999; 115:34S-41S.
  10. Kollef, M.H., et al. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-474.
  11. Smith, T.L., et al. Emergence of vancomycin resistance in Staphylococcus aureus. NEJM 1999;340(7):493-501.
  12. Nema, S. et al. Emerging bacteria drug resistance in hospital practice. Indian J Med Sci 1997; 51 (8): 275-280.
  13. File, Jr., T.M. Overview of resistance in the 1990s, Chest 1999;115:3S-8S.
  14. Moellering, Jr., R.C. Antibiotic resistance: Lessons for the future. Clin Infec Dis 1998:27(Sup.1);S135-140.
  15. Moellering, Jr., R.C. A novel antimicrobial agent joins the battle against resistant bacteria. Ann Int Med 1999;130(2):155-157.

About the author

Wesley Mark Todd, M.D., is the Therapeutic Area Clinical Director for Antibacterials at Pharmacia & Upjohn.

Return to: Infection Control Home